HLA-B Matching Prolongs Allograft Survival in Islet Cell Transplantation
Cell Transplantation · 2023
DOI: 10.1177/09636897231166529 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Transplantation, 2023. Verfasst von Joana R N Lemos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Research Institute (DRI) and Clinical Cell Transplant Program, Miller School of Medicine, University of Miami, Miami, FL, USA. Hauptthemen laut MEDLINE: Hypoglycemia, Islets of Langerhans Transplantation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS, NCRR NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Islet cell transplantation (ITx) is an effective therapeutic approach for selected patients with type 1 diabetes with hypoglycemia unawareness and severe hypoglycemia events. In organ transplantation, human leukocyte antigen (HLA) mismatching between donor and recipient negatively impacts transplant outcomes. We aimed to determine whether HLA matching has an impact on islet allograft survival. Forty-eight patients were followed up after islet transplantation at our institution from 2000 to 2020 in a retrospective cohort. Patients underwent intrahepatic ITx or laparoscopic omental approach. Immunosuppression was dependent upon the protocol. We analyzed HLA data restricted to A, B, and DR loci on allograft survival using survival and subsequent multivariable analyses. Patients were aged 42.8 ± 8.4 years, and 64.3% were female. Diabetes duration was 28.6 ± 11.6 years. Patients matching all three HLA loci presented longer graft survival ( P = 0.030). Patients with ≥1 HLA-B matching had longer graft survival compared with zero matching ( P = 0.025). The number of HLA-B matching was positively associated with time of graft survival (Spearman’s rho = 0.590; P = 0.034). Analyses adjusted for confounders showed that ≥1 matching for HLA-B decreased the risk of allograft failure ( P = 0.009). Our data suggest that HLA-B matching between recipients and donors improved islet allograft survival. Matching all three HLA loci (A, B, and DR) was also associated with prolonged islet allograft survival. Prospective studies and a larger sample size are warranted to validate our findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Diabetes Research Institute (DRI) and Clinical Cell Transplant Program, Miller School of Medicine, University of Miami, Miami, FL, USA.
- Division of Cellular Transplantation, Department of Surgery, Miller School of Medicine, University of Miami, Miami, FL, USA.
ORCID-Profile: Rodolfo Alejandro
Förderung
- NIDDK NIH HHS
- NCRR NIH HHS
- NCATS NIH HHS
- Florida Department of State
- Diabetes Research Institute Foundation
- Miami Clinical and Translational Science Institute
- Juvenile Diabetes Research Foundation International
- NIH Clinical Center
Zitieren
APA
Lemos, J. R. N., Baidal, D. A., Poggioli, R., Fuenmayor, V., Chavez, C., Alvarez, A., Ricordi, C., & Alejandro, R. (2023). HLA-B Matching Prolongs Allograft Survival in Islet Cell Transplantation. Cell Transplantation. https://doi.org/10.1177/09636897231166529
Vancouver
Lemos JRN, Baidal DA, Poggioli R, Fuenmayor V, Chavez C, Alvarez A, et al. HLA-B Matching Prolongs Allograft Survival in Islet Cell Transplantation. Cell Transplantation. 2023. doi:10.1177/09636897231166529
BibTeX
@article{Lemos2023,
author = {Lemos, Joana R N and Baidal, David A and Poggioli, Raffaella and Fuenmayor, Virginia and Chavez, Carmen and Alvarez, Ana and Ricordi, Camillo and Alejandro, Rodolfo},
title = {HLA-B Matching Prolongs Allograft Survival in Islet Cell Transplantation},
journal = {Cell Transplantation},
year = {2023},
doi = {10.1177/09636897231166529}
}
EUVIMED